Proposed Acquisition of ResApp Health by Pfizer Australia Holdings Pty Limited, a wholly-owned subsidiary of Pfizer Inc, for $0.208 cash per share by scheme of arrangement.
Your Vote is Important
Your Directors unanimously recommend that you vote in favour of the Scheme, in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of ResApp Health Shareholders.
The Independent Expert has concluded that the Scheme is in your best interests, in the absence of a superior proposal.
How to Vote
Voting on the Scheme Resolution will be by poll.
ResApp Shareholders entitled to vote at the Scheme Meeting can vote:
by attending the Scheme Meeting in person or virtually;
by appointing a proxy, attorney or corporate representative to attend the Scheme Meeting in person or virtually and vote on their behalf; or
by submitting their vote online at https://investor.automic.com.au/#/loginsah.
Appointing a proxy
ResApp Shareholders who are unable, or do not wish to, attend the Scheme Meeting are strongly encouraged to submit their votes by proxy instead.
ResApp Shareholders who have elected to receive notices of meeting electronically will receive an email with a personalised link to vote online.
Proxy Forms can be lodged online at https://investor.automic.com.au/#/loginsah by following the below instructions:
Login to the Automic website using the holding details as shown on the Proxy Form. Click on ‘Meetings’ – ‘Vote’. To use the online lodgement facility, Shareholders who have not elected to receive notices of meetings electronically will need their holder number (Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) as shown on the front of the Proxy Form. Shareholders who have received a personalised link will need their postcodes or, in the case of overseas Shareholders, their country code.
You will be taken to have signed a Proxy Form and appointed a proxy if you submit your proxy online in accordance with the instructions on the website. Please read the instructions for online proxy submissions carefully before you lodge your proxy.
The online proxy appointment must be received by ResApp by no later than 2:00pm (AEST) on 31 August 2022 to be effective.
The Scheme Booklet will be dispatched to ResApp shareholders shortly after its release to ASX. ResApp shareholders who have elected to receive electronic communications will receive an email containing instructions about how to view or download a copy of the Scheme booklet, as well as instructions on how to lodge their proxies for the Scheme Meeting online. ResApp shareholders who have elected to receive communications via post will receive a printed copy of the Scheme Booklet together with a personalised proxy form. All other ResApp shareholders will receive a letter, together with a personalised proxy form, with instructions about how to view or download a copy of the Scheme Booklet.
ResApp Shareholders may appoint a proxy by completing and returning the Proxy Form to ResApp or the Share Registry by either posting or by sending, delivering, or lodging it online as follows:
(i) In Person:
Level 5, Philip Street, Sydney NSW 2000
(ii) By Mail:
GPO Box 5193
Sydney NSW 2001
(iii) By Email:
(iv) By Facsimile:
See Online instructions above.
(vi) Mobile Device:
Scan the QR code on your Proxy Form and follow the prompts. You will need your SRN or HIN as shown on your Proxy Form.
The signed Proxy Form (and an original or certified copy of any power of attorney under which it has been signed, unless already provided) must be received by ResApp or the Share Registry by no later than 2:00pm (AEST) on 5 September 2022, to be effective.